Estrogen receptor (ER)âα36 and autophagy have each independently been reported to promote the proliferation of liver cancer cells; however, the association between them has not been explored. Therefore, the present study aimed to investigate the role and the underlying mechanism of ERâα36 in the regulation of autophagy in liver cancer cells. The proliferation of liver cancer cell variants was examined by colony formation assay. A xenograft tumor model in nude mice was used to examine the role of ERâα36 in malignant proliferation of liver cancer cells in vivo. Autophagic flux and lysosomal localization were assessed with immunofluorescence and confocal microscopy. The levels of ERâα36, LAMP1, AKT, p62 and LC3ââ ¡/â in liver cancer cell variants, and tumors formed by HepG2 cell variants in the nude mice were examined using Western blot and immunohistochemistry. The results revealed that ERâα36 knockdown impaired autophagic flux by increasing lysosomal membrane permeabilization (LMP) and blocking lysosomal degradation. ERâα36 knockdown also significantly inhibited the proliferation of liver cancer cells and orthotopic liver xenograft tumors. In addition, decreased AKT phosphorylation and the juxtanuclear clustering of lysosomes were observed in the liver cancer cells with ERâα36 knockdown. In vitro experiments using the AKT inhibitor MKâ2206 indicated that AKT is involved in the ERâα36 knockdownâinduced changes in LMP and lysosomal localization in liver cancer cells. In summary, the present study revealed that ERâα36 plays a role in regulating the autophagy and proliferation of liver cancer cells, which is associated with the modulation of AKT signaling, LMP and lysosome localization. These findings highlight an important role of ERâα36 in liver tumorigenesis.
ERâα36 knockdown is associated with lysosomal dysfunction and proliferation inhibition in liver cancer cells.
ER-α36 敲低与肝癌细胞溶酶体功能障碍和增殖抑制有关
阅读:6
作者:He Huanhuan, Wang Xuan, Wei Zhixuan, Wang An, Fang Xiangyue, He Hanbo, Wu Zhuorui, Shu Xiji, Sun Binlian, Chen Qiongxia, Huang Xuan, Zhou Hongyan, Liu Yuchen, Fu Zhengqi
| 期刊: | Molecular Medicine Reports | 影响因子: | 3.500 |
| 时间: | 2025 | 起止号: | 2025 Oct |
| doi: | 10.3892/mmr.2025.13649 | 研究方向: | 细胞生物学 |
| 疾病类型: | 肝癌 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
